PMID- 36567181 OWN - NLM STAT- MEDLINE DCOM- 20230223 LR - 20230402 IS - 1879-1972 (Electronic) IS - 1054-139X (Linking) VI - 72 IP - 3 DP - 2023 Mar TI - Clinical Worsening in an Adolescent With Pleural Tuberculosis. PG - 480-482 LID - S1054-139X(22)00786-8 [pii] LID - 10.1016/j.jadohealth.2022.11.013 [doi] AB - A 17-year-old previously healthy female presented with unilateral chest pain and dyspnea. Chest radiographs demonstrated a unilateral pleural effusion and pneumonia. Pleural fluid bacterial cultures were negative; acid-fast cultures grew Mycobacterium tuberculosis. Two months after starting appropriate therapy, she had a recrudescence of symptoms and reaccumulation of the pleural fluid. Her tuberculosis antibiotic regimen was expanded, the effusion drained, and systemic corticosteroids initiated, resulting in rapid clinical improvement. Cultures of the second pleural fluid collection were negative. Her clinical deterioration was due to immune reconstitution inflammatory syndrome (IRIS). IRIS can be seen within the first several months of starting tuberculosis therapy and can result in paradoxical worsening of symptoms or radiographic findings in adolescents who are on the appropriate therapy. IRIS is a diagnosis of exclusion after drug resistance and medication malabsorption, intolerance, and nonadherence are excluded. Therapy includes nonsteroidal anti-inflammatory agents for milder reactions and systemic corticosteroids for more severe IRIS cases. CI - Copyright (c) 2022 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. FAU - Cruz, Andrea T AU - Cruz AT AD - Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Electronic address: acruz@bcm.edu. FAU - Starke, Jeffrey R AU - Starke JR AD - Department of Pediatrics, Baylor College of Medicine, Houston, Texas. LA - eng PT - Journal Article DEP - 20221223 PL - United States TA - J Adolesc Health JT - The Journal of adolescent health : official publication of the Society for Adolescent Medicine JID - 9102136 RN - 0 (Adrenal Cortex Hormones) RN - 0 (Anti-Bacterial Agents) SB - IM MH - Humans MH - Female MH - Adolescent MH - *Tuberculosis, Pleural/drug therapy MH - *Mycobacterium tuberculosis MH - Adrenal Cortex Hormones/therapeutic use MH - Anti-Bacterial Agents/therapeutic use MH - *Immune Reconstitution Inflammatory Syndrome/drug therapy OTO - NOTNLM OT - Immune reconstitution inflammatory syndrome OT - Paradoxical worsening OT - Pleural tuberculosis EDAT- 2022/12/26 06:00 MHDA- 2023/02/25 06:00 CRDT- 2022/12/25 21:54 PHST- 2022/07/23 00:00 [received] PHST- 2022/11/12 00:00 [revised] PHST- 2022/11/16 00:00 [accepted] PHST- 2022/12/26 06:00 [pubmed] PHST- 2023/02/25 06:00 [medline] PHST- 2022/12/25 21:54 [entrez] AID - S1054-139X(22)00786-8 [pii] AID - 10.1016/j.jadohealth.2022.11.013 [doi] PST - ppublish SO - J Adolesc Health. 2023 Mar;72(3):480-482. doi: 10.1016/j.jadohealth.2022.11.013. Epub 2022 Dec 23.